Calcium supplementation in premenstrual syndrome
- 246 Downloads
Objective:To determine the efficacy of calcium supplementation in women with premenstrual syndrome (PMS).
Design:Randomized, double-blind crossover trial.
Setting:Outpatient medical clinic of a large city hospital.
Particlpants:Seventy-eight women were initially screened. Trial selection was based on a history of recurrent PMS symptoms and on the results of a prospective assessment of daily symptom scores. Only women with symptom scores during the late luteal phase that were at least 50% greater than those during the intermenstrual phase were selected. Thirty-three women completed the trial.
Intervention:A preliminary evaluation included physical examination, routine laboratory tests, dietary assessment, and psychiatric evaluation. Each participant received six months of treatment involving three months of daily calcium supplementation (1,000 mg of calcium carbonate) and three months of placebo.
Measurements:Efficacy was assessed prospectively by changes in daily symptom scores over a six-month period and retrospectively by an overall global assessment. Multivariate repeated measures analysis of variance on symptom ratings derived from daily PMS symptom scores demonstrated a reduction in symptoms on calcium treatment during both the luteal (p=0.011) and the menstrual phases (p=0.032) of the reproductive cycle. Calcium supplementation had no effect during the intermenstrual phase. Retrospective assessment of overall symptoms confirmed this reduction: 73% of the women reported fewer symptoms during the treatment phase on calcium, 15% preferred placebo, and 12% had no clear preference. Three premenstrual factors (negative affect [p=0.045]; water retention [p=0.003]; pain [p=0.036]) and one menstrual factor (pain [p=0.02]) were significantly alleviated by calcium.
Conclusion:Calcium supplementation is a simple and effective treatment for premenstrual syndrome, but further studies will be needed to determine its precise role in PMS.
Key wordscalcium premenstrual syndrome outpatient care
Unable to display preview. Download preview PDF.
- 1.Frank RT. The hormonal causes of premenstrual tension. Arch Neurol Psychiatry. 1931; 26:1053–7.Google Scholar
- 5.Coppen AJ, Milne HB, Outram DH, Weber JCP. Dytide, norethisterone and a placebo in the premenstrual syndrome. Clin Trial J. 1969; 9:33–5.Google Scholar
- 8.O’Brien PM, Faratian B, Gaspan A, et al. Quantification of premenstrual syndrome. In Taylor RW, ed. Premenstrual syndrome. London, Medical News-Tribune Ltd, 1983; 7–12.Google Scholar
- 11.Abraham GE, Hargrove JT. Effect of vitamin B6 on premenstrual symptomatology in women with premenstrual tension syndrome: a double blind crossover study. Infertility. 1980; 3:155–65.Google Scholar
- 12.Israel SL. Premenstrual tension. JAMA 1938; 110:1721–31.Google Scholar
- 14.Moos R. The development of a menstrual distress questionnaire. Psychomat Med. 1968; 30:853–66.Google Scholar
- 18.McCarthy DM, Sheehan JD. The role of calcium ions in salivary secretion. J Physiol. 1968; 184:81–82p.Google Scholar
- 20.Lehninger AL, Carafole E, Rossi CS. Energy-linked ion movements in mitochondrial systems. Advances Enzymol. 1967; 29:259–320.Google Scholar
- 21.Munday M. Progesterone and aldosterone levels in the premenstrual syndrome. J Endocrinol. 1977; 73:21p.Google Scholar
- 22.Munday M, Brush MG, Taylor RW. Correlates between progesterone, oestradiol and aldosterone levels in the premenstrual syndrome. Clin Endocrinol. 1981; 14:1–9.Google Scholar
- 23.Butt WR, Watts JF, Holder G. The biochemical background to premenstrual syndrome. In Taylor RW, ed. Premenstrual syndrome. London, News-Tribune Ltd., 1983; 16–24.Google Scholar
- 26.Andersch B, Abrahamsson L, Wenderstem C, et al. Hormone profiles in premenstrual tension: effects of bromocriptine and diuretics. Clin Endocrinol. 1979; 11:657–64.Google Scholar
- 27.Pritkin RM, Reynolds WA, Williams GA, Hargis KH. Calcium-regulating hormones during the menstrual cycle. J Clin Endocrinol Metabol. 1978; 47:626–32.Google Scholar
- 28.Gray TK, McAdoo T, Hartley L, Lester GE, Thierry M. Fluctuations of serum concentrations of 1,25-dihydroxyvitamin D3 during the menstrual cycle. Am J Obstet Gynecol. 1982; 14:880–4.Google Scholar